Market Tracker

09/22 5:16pm ET

TG Therapeutics Inc (NASDAQ:TGTX)

11.95
Delayed Data
As of Sep 22
 +0.15 / +1.27%
Today’s Change
4.10
Today|||52-Week Range
15.35
+156.99%
Year-to-Date
No recent news for TG Therapeutics Inc.

Today’s Trading

Previous close11.80
Today’s open11.85
Day’s range11.65 - 12.00
Volume768,812
Average volume (3 months)1,420,345
Market cap$822.6M
Dividend yield--
Data as of 4:00pm ET, 09/22/2017

Growth & Valuation

Earnings growth (last year)-15.94%
Earnings growth (this year)-11.87%
Earnings growth (next 5 years)--
Revenue growth (last year)0.00%
P/E ratioNM
Price/Sales1,496.53
Price/Book18.92

Competitors

 Today’s
change
Today’s
% change
BYSIBeyondspring Inc-0.82-2.09%
PTCTPTC Therapeutics Inc-1.53-7.63%
KERXKeryx Biopharmaceuti...+0.03+0.43%
HRTXHeron Therapeutics I...+0.05+0.33%
Data as of 4:14pm ET, 09/22/2017

Financials

Next reporting dateNovember 6, 2017
EPS forecast (this quarter)-$0.42
Annual revenue (last year)$152.4K
Annual profit (last year)-$78.3M
Net profit margin-51,353.45%

Profile

Sector
Health Technology
Industry
Biotechnology
Executive Chairman, President &
CEO
Michael Sean Weiss
Chief Financial Officer, Secretary &
Treasurer
Sean A. Power
Corporate headquarters
New York, New York

Forecasts